Category Archives: Debbie Wasserman Schultz, Barack Obama, Health Care, Voting Rights, GOP 2012, Mitt Romney,

News roundup: November 1, 2011

Last week, the Justice Department filed a brief to challenge a GOP proposal in Texas that redraws state districts to explicitly dilute the electoral influence of minority voters. This effort in Texas is yet another attempt by Republicans to overhaul state election laws to disenfranchise voters. “There’s a national assault on voting rights,” said Wendy Weiser of New York University’s Brennan Center for Justice, “the most significant assault in decades.”

The Obama campaign launched Young Americans for Obama last Monday, which seeks to involve more young people in the President’s re-election bid. Campaign spokesman Drew Anderson kicked off the initiative with a conference call with student reporters. The hot topic was the President’s recent announcement to give college graduates an opportunity to consolidate their federal student loans.

Mitt Romney’s disregard for the foreclosure crisis has begun to turn heads, especially in Nevada, the state with the highest foreclosure rate in the country. The Las Vegas Sun points out that although Romney and his Republican cohorts advocate leaving the market to its own devices, they forget that it was the market—along with a lack of oversight—that caused the foreclosure crisis in the first place.

While the Republican presidential candidates continue spewing hyper-partisan rhetoric, President Obama is proposing real solutions to get the economy moving again, writes DNC chair Debbie Wasserman Schultz. In addition to the American Jobs Act, the President has taken steps to make it easier for some homeowners to refinance their mortgages and to help students save money and better manage their loans when they graduate.

With the number of prescription drug shortages tripling between 2005 and 2010, price-gouging vendors have been able to mark up prices of drugs in short supply by a whopping 650 percent. President Obama's most recent executive order requires the FDA to expand reporting to prevent future shortages and work with the Department of Justice to investigate illegal price gouging.